Eversept Partners »

Korro Bio shares owned by Eversept Partners

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $999k 21k 47.89

More positions owned by Eversept Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
United Therapeutics Corporation (UTHR)
GSK Sponsored Adr (GSK)
Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Syndax Pharmaceuticals (SNDX)
Vaxcyte (PCVX)
Uniqure Nv SHS (QURE)
Hca Holdings (HCA)
Miragen Therapeutics (VRDN)
Zimvie (ZIMV)
Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals (IONS)
PerkinElmer (RVTY)
Travere Therapeutics (TVTX)

View all positions for Eversept Partners

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Driehaus Capital Management
FMR
Point72 Asset Management
Cormorant Asset Management
BlackRock
Siren
TCG Crossover Management
Vanguard Group
Qiming U.S. Ventures Management
Tri Locum Partners
72 Investment Holdings
Polar Capital Holdings
Millennium Management

View all funds holding Korro Bio